Total Payments
$7,458
2024 Payments
$819.45
Companies
52
Transactions
477
Medicare Patients
8,690
Medicare Billing
$599,225
Payment Breakdown by Category
Food & Beverage$7,378 (98.9%)
Education$79.99 (1.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,378 | 476 | 98.9% |
| Education | $79.99 | 1 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,298 | 69 | $0 (2024) |
| PFIZER INC. | $783.01 | 69 | $0 (2024) |
| Amgen Inc. | $651.48 | 46 | $0 (2024) |
| ABBVIE INC. | $639.25 | 41 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $638.59 | 42 | $0 (2022) |
| Astellas Pharma US Inc | $475.63 | 22 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $386.39 | 28 | $0 (2022) |
| Lilly USA, LLC | $356.69 | 23 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $307.31 | 24 | $0 (2024) |
| GlaxoSmithKline, LLC. | $274.93 | 17 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $819.45 | 43 | Astellas Pharma US Inc ($159.75) |
| 2023 | $915.64 | 48 | Astellas Pharma US Inc ($170.59) |
| 2022 | $650.84 | 37 | ABBVIE INC. ($153.87) |
| 2021 | $1,006 | 64 | PFIZER INC. ($144.12) |
| 2020 | $1,025 | 69 | AstraZeneca Pharmaceuticals LP ($165.36) |
| 2019 | $863.13 | 61 | AstraZeneca Pharmaceuticals LP ($154.58) |
| 2018 | $1,132 | 77 | AstraZeneca Pharmaceuticals LP ($328.97) |
| 2017 | $1,048 | 78 | AstraZeneca Pharmaceuticals LP ($235.47) |
All Payment Transactions
477 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $26.87 | General |
| Category: Biological | ||||||
| 11/07/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: VACCINES | ||||||
| 11/04/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: DERMATOLOGY | ||||||
| 10/03/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: Biological | ||||||
| 09/26/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: VACCINES | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Respiratory | ||||||
| 09/12/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $55.05 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 09/09/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/22/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: Biological | ||||||
| 08/21/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: VACCINES | ||||||
| 08/20/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Neurology | ||||||
| 08/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: Respiratory | ||||||
| 08/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Respiratory | ||||||
| 07/11/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: NEUROSCIENCE | ||||||
| 06/20/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Inflammation | ||||||
| 06/10/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: VACCINES | ||||||
| 06/07/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Diabetes | ||||||
| 05/28/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: Biological | ||||||
| 05/13/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Endocrinology | ||||||
| 05/09/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Respiratory | ||||||
| 04/30/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,738 | 2,386 | $332,102 | $163,451 |
| 2022 | 16 | 1,942 | 2,648 | $316,432 | $147,471 |
| 2021 | 22 | 2,950 | 3,921 | $337,956 | $166,702 |
| 2020 | 23 | 2,060 | 2,838 | $301,094 | $121,602 |
Total Patients
8,690
Total Services
11,793
Medicare Billing
$599,225
Procedure Codes
78
All Medicare Procedures & Services
78 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 354 | 704 | $147,850 | $53,574 | 36.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 293 | 554 | $80,330 | $31,216 | 38.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 69 | 69 | $20,550 | $19,282 | 93.8% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 115 | 116 | $18,560 | $14,904 | 80.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 192 | 192 | $16,320 | $14,556 | 89.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 73 | 73 | $12,775 | $8,915 | 69.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 250 | 251 | $8,805 | $7,322 | 83.2% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 115 | 115 | $8,625 | $4,474 | 51.9% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 48 | 53 | $5,035 | $2,530 | 50.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 67 | 67 | $2,210 | $1,954 | 88.4% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 53 | 53 | $2,385 | $1,775 | 74.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 19 | 19 | $3,800 | $1,155 | 30.4% |
| 0134A | Adm sarscv2 bvl 50mcg/.5ml a | Office | 2023 | 26 | 26 | $1,950 | $1,011 | 51.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 38 | $1,330 | $371.70 | 27.9% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 12 | 14 | $532.00 | $226.80 | 42.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 18 | 19 | $1,045 | $183.94 | 17.6% |
| 91313 | Sarscov2 vac bvl 50mcg/0.5ml | Office | 2023 | 23 | 23 | $0.23 | $0.23 | 100.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 379 | 817 | $158,628 | $63,880 | 40.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 281 | 520 | $70,036 | $28,007 | 40.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 205 | 205 | $17,405 | $14,288 | 82.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 77 | 77 | $13,600 | $9,683 | 71.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 309 | 311 | $9,490 | $8,723 | 91.9% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 198 | 198 | $14,560 | $7,344 | 50.4% |
| 0064A | Adm sarscov2 50mcg/0.25mlbst | Office | 2022 | 135 | 135 | $8,775 | $5,058 | 57.6% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 91 | 114 | $7,410 | $3,981 | 53.7% |
About Robert Resnik
Robert Resnik is a Internal Medicine healthcare provider based in Cary, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346209400.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Robert Resnik has received a total of $7,458 in payments from pharmaceutical and medical device companies, with $819.45 received in 2024. These payments were reported across 477 transactions from 52 companies. The most common payment nature is "Food and Beverage" ($7,378).
As a Medicare-enrolled provider, Resnik has provided services to 8,690 Medicare beneficiaries, totaling 11,793 services with total Medicare billing of $599,225. Data is available for 4 years (2020–2023), covering 78 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Cary, NC
- Active Since 03/18/2006
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1346209400
Products in Payments
- FARXIGA (Drug) $892.20
- Aimovig (Biological) $358.93
- SOLIQUA 100/33 (Biological) $295.33
- UBRELVY (Drug) $259.75
- Livalo (Drug) $236.78
- VRAYLAR (Drug) $221.80
- XARELTO (Drug) $200.61
- Veozah (Drug) $198.14
- CHANTIX (Drug) $191.71
- PREVNAR 20 (Biological) $190.89
- INVOKANA (Drug) $185.78
- TOUJEO (Drug) $180.94
- EMGALITY (Drug) $159.91
- BEVESPI AEROSPHERE (Drug) $155.30
- Prolia (Biological) $132.40
- JARDIANCE (Drug) $128.71
- Myrbetriq (Drug) $120.79
- SOLIQUA (Drug) $118.00
- PREVNAR 13 (Biological) $105.45
- Otezla (Drug) $100.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Cary
Dr. Sameh Mobarek, M.d, M.D
Internal Medicine — Payments: $460,076
Internal Medicine $460,076
Dr. Siddhartha Rao, M.d, M.D
Internal Medicine — Payments: $236,599
Internal Medicine $236,599
Dr. Nidhi Malhotra, M.d, M.D
Internal Medicine — Payments: $163,940
Internal Medicine $163,940
Zehra Husain, M.d, M.D
Internal Medicine — Payments: $29,068
Internal Medicine $29,068
Mark Graham, M.d, M.D
Internal Medicine — Payments: $26,073
Internal Medicine $26,073
Dr. Jeffrey Daw, M.d, M.D
Internal Medicine — Payments: $14,978
Internal Medicine $14,978